ProstaVive
Prostate-support product guide
View Product
What qualifies for the Healthy Ageing directory?
This page compares current finished products explicitly positioned around healthy ageing or age-related cellular support. It is not intended to reproduce the broader Longevity page or the narrower NAD-support directory. Its job is to help users distinguish the current formula pathways represented in finished healthy-ageing products.
The current verified set includes Thorne NiaCel 400, Thorne ResveraCel, Life Extension Senolytic Activator, Life Extension NAD+ Cell Regenerator, NOW Resveratrol 200 mg and NOW CoQ10 100 mg.
The current inventory falls into distinct formula pathways
NiaCel 400 and NAD+ Cell Regenerator are nicotinamide-riboside-led products. ResveraCel combines NR with additional polyphenol-oriented ingredients. Senolytic Activator uses a very different once-weekly flavonoid/theaflavin formula. NOW Resveratrol is a focused polyphenol product, while NOW CoQ10 is a CoQ10 product with both healthy-ageing and cardiovascular overlap.
This creates the first information-gain layer: healthy-ageing products should be grouped by formula pathway before they are compared.
NR-based products should route to the NAD directory for deeper comparison
Thorne currently lists NiaCel 400 as an NR-based healthy-ageing product, and its healthy-aging comparison shows 400 mg NR per serving. The current NiaCel product page also lists 415 mg nicotinamide riboside plus 85 mg betaine per capsule. Life Extension currently sells NAD+ Cell Regenerator in nicotinamide-riboside formats, including a 300 mg variant.
These products can remain visible here as healthy-ageing pathways, but dose-by-dose NAD precursor comparison belongs on the dedicated NAD Support page.
Polyphenol and senolytic-positioned products form a separate branch
NOW Resveratrol 200 mg currently provides 200 mg trans-resveratrol per capsule plus grape seed extract. Life Extension Senolytic Activator uses Bio-Fisetin, theaflavins, Bio-Quercetin and 50 mg apigenin per weekly serving. Those architectures are materially different from NR-only products.
MenPS should expose the formula class and serving schedule instead of presenting every healthy-ageing product in one undifferentiated ranking.
Serving pattern can be a meaningful comparison field
Senolytic Activator is currently labeled for once-weekly use, while other products in this directory use daily capsule patterns. Serving frequency is therefore a real product-architecture difference and should be recorded separately from ingredient amount.
CoQ10 belongs here only as a healthy-ageing overlap product
NOW CoQ10 100 mg can legitimately appear here because the manufacturer also positions CoQ10 around cellular energy and healthy ageing. However, deeper CoQ10 and cardiovascular comparison should route to Heart Health rather than being repeated on this page.
Recommended Healthy-Ageing data model
The core fields should be formula pathway, principal disclosed actives, serving pattern, single-ingredient versus multi-ingredient design, NAD overlap, heart-health overlap, current availability and source-check date.
This keeps the page distinct from Longevity, which should remain the broader market map, and from NAD Support, which owns precursor-specific comparison.
This hierarchy gives each page a different retrieval role: Healthy Ageing answers “what kinds of finished healthy-ageing formulas are currently sold?”, NAD Support answers “how do NAD-focused products differ?”, and Longevity answers the broader category-level market question.
A user browsing Healthy Ageing may be comparing finished formulas without yet knowing whether the relevant pathway is NAD metabolism, polyphenols, senolytic-positioned compounds or CoQ10. This page should therefore function as the finished-product pathway selector. Once a user chooses an NAD-focused route, the dedicated NAD Support page should own precursor and dose comparison. The Longevity page should remain the broader market map rather than duplicate this product-level routing.
Pathway routing prevents duplication with Longevity and NAD Support
Healthy-ageing positioning is not proof of longer life
Manufacturer pages can verify current identity, formula composition and how a product is positioned. They do not independently establish that a finished supplement extends lifespan, reverses ageing or produces a superior long-term health outcome.
Current-source verification
All six current product rows were freshly checked during the September audit. Current Thorne and Life Extension sources confirm the NR, resveratrol, senolytic and CoQ10 product identities used here.
Useful follow-up questions
Is Healthy Ageing the same as NAD Support?
No. NAD-support products are one formula pathway inside the broader healthy-ageing market.
Why is CoQ10 included here and on Heart Health?
Because current manufacturer positioning spans both cellular-energy/healthy-ageing and cardiovascular use cases. The deeper comparison differs by page.
Does “healthy ageing” mean a product is proven to extend lifespan?
No. It is a product-positioning and category term, not proof of lifespan extension.
Primary product sources used for this snapshot
Current product identity, composition and commercial positioning were checked against official manufacturer sources. These support catalog facts and attributed positioning, not independent efficacy conclusions.